10-(1,3-Benzothiazol-2-yl)-2,3,6,7-tetrahydro-1H,5H-11H-[1]benzopyrano[6,7,8-ij]-quinoliz-11-one
✍ Scribed by Jasinski, Jerry P. ;Li, Yu
- Publisher
- International Union of Crystallography
- Year
- 2002
- Tongue
- English
- Weight
- 245 KB
- Volume
- 58
- Category
- Article
- ISSN
- 1600-5368
No coin nor oath required. For personal study only.
✦ Synopsis
Single-crystal X-ray study T = 296 K Mean '(C±C) = 0.004 A Ê Disorder in main residue R factor = 0.045 wR factor = 0.143 Data-to-parameter ratio = 15.0 For details of how these key indicators were automatically derived from the article, see http://journals.iucr.org/e.
📜 SIMILAR VOLUMES
## 3-(3-Methoxybenzoyl 6,6-trimethyl-4,5,6,7-tetrahydrospiro[benzo[b] furan-2(3H),3 0 0 0 (2 0 0 0 H)-1H-indole]-4,2 0 0 0 -dione
The title compound, C 28 H 22 ClNO 3 , has two crystallographically independent molecules in the asymmetric unit. The pyrrolidine ring (A) of the pyrrolizine system adopts an envelope conformation in both molecules, whereas the other five-membered ring (B) adopts an envelope conformation in one mole
3-(4-Methoxyphenyl)-1 0 0 0 ,6,6-trimethyl-4,5,6,7-tetrahydrospiro[1-benzofuran-2,3 0 0 0 (3H,2 0 0 0 H)-1H-indole]-2 0 0 0 ,4-dione